SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000885590-20-000060
Filing Date
2020-11-03
Accepted
2020-11-03 17:08:38
Documents
110
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bhc-20200930.htm   iXBRL 10-Q 3475880
2 EX-31.1 exhibit311q32020.htm EX-31.1 10075
3 EX-31.2 exhibit312q32020.htm EX-31.2 10110
4 EX-32.1 exhibit321q32020.htm EX-32.1 6590
5 EX-32.2 exhibit322q32020.htm EX-32.2 6604
  Complete submission text file 0000885590-20-000060.txt   14016816

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhc-20200930.xsd EX-101.SCH 86284
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhc-20200930_cal.xml EX-101.CAL 134351
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhc-20200930_def.xml EX-101.DEF 510283
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhc-20200930_lab.xml EX-101.LAB 938883
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhc-20200930_pre.xml EX-101.PRE 684610
11 EXTRACTED XBRL INSTANCE DOCUMENT bhc-20200930_htm.xml XML 2744706
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14956 | Film No.: 201284331
SIC: 2834 Pharmaceutical Preparations